Prognostic Factors of Human Immunodeficiency Virus-Infected Patients on Chronic Hemodialysis.

Blood Purif 2017 3;44(3):244-250. Epub 2017 Oct 3.

Department of Nephrology, Hospital de Santa Cruz, Lisbon, Portugal.

Background/aims: The number of human immunodeficiency virus (HIV)-infected patients on hemodialysis (HD) have increased, and their prognostic factors are still poorly clarified. The study aimed to identify factors that can influence the survival of HIV-infected patients on HD.

Methods: We performed a retrospective cohort study of 44 HIV-infected patients on HD.

Results: A total of 17 patients (39%) died. Median survival on HD was 30.8 months and the survival rate at 1 and 5 years was 82.5 and 62.9%, respectively. Male (relative risk [RR] 3.1, p = 0.040) and blacks (RR 2.5, p = 0.037) had higher risk of death. The patients who died had a shorter duration of HIV infection (p = 0.028), had a higher viral load (p = 0.044), more opportunistic infections (p = 0.013), and a lower serum albumin (p = 0.009). Lower serum albumin, nonsexual HIV transmission, viral load, opportunistic infections, and usage of catheters were associated with lower survival.

Conclusion: Several demographic, viral, and dialysis variables may help to predict survival of this population. The intervention in these factors could improve their prognosis.

Download full-text PDF

Source Listing
July 2018
4 Reads

Publication Analysis

Top Keywords

hiv-infected patients
lower serum
human immunodeficiency
serum albumin
prognostic factors
opportunistic infections
viral load
died shorter
risk death
patients died
death patients
shorter duration
hiv infection
0028 higher
higher risk
infection 0028
higher viral
duration hiv
blacks 0037

Similar Publications

Survival and morbidity of HIV patients on hemodialysis and peritoneal dialysis: one center's experience and review of the literature.

Int Urol Nephrol 2006 ;38(2):331-8

Nephrology Ward, Shariati Hospital, North Kargar Street, Postal code: 14114, Tehran, Iran.

Background: Controversy continues concerning the morbidity and mortality of HIV-infected ESRD patients on the two dialysis options. This article presents our experience with complications and survival rate among our HIV-infected ESRD patients on peritoneal dialysis and hemodialysis. We reviewed the literature on this subject. Read More

View Article
March 2007

Maintenance hemodialysis in patients with HIV-associated nephropathy.

Clin Nephrol 1998 Dec;50(6):367-74

Department of Medicine, Bronx-Lebanon Hospital Center, Bronx, New York, USA.

Objective: End-stage renal disease (ESRD) patients infected with human immunodeficiency virus (HIV) have poor survival on maintenance hemodialysis. Only a few studies have evaluated survival time on the basis of demographic and clinical factors. The clinical category of the HIV infection and total CD4 counts are commonly considered determining factors of survival in these HIV-infected dialysis patients. Read More

View Article
December 1998

Outcome and prognostic factors in HIV-1-infected patients on dialysis in the cART era: a GESIDA/SEN cohort study.

J Acquir Immune Defic Syndr 2011 Aug;57(4):276-83

Hospital Sant Jaume de Olot University of Girona, Girona, Spain.

Background: Prognosis of HIV-infected patients on dialysis has improved. Few studies have compared survival between HIV-infected and HIV-negative patients on dialysis in the combined antiretroviral therapy (cART) era. We compared the outcome of HIV-infected patients on dialysis with a matched HIV-negative cohort. Read More

View Article
August 2011

Effect of hemodialysis and antiretroviral therapy on plasma viral load in HIV-1 infected hemodialysis patients.

Clin Nephrol 1999 Jan;51(1):40-4

Department of Medicine, University of Texas Medical Branch at Galveston, 77555, USA.

Background: Plasma viral load has become an important test in predicting the progress of HIV-1 infected patients. The higher the viral load the faster is the progression to AIDS. As HIV-1 infected hemodialysis (HD) patients have higher mortality and morbidity than HIV-1 infected non-dialysis patients, and as all the blood tests in the HD patients are drawn during HD, we measured the effect of HD and antiretroviral therapy on viral load in HIV-1 infected HD patients. Read More

View Article
January 1999